PDS Biotechnology (PDSB) Other Accumulated Expenses (2014 - 2018)

PDS Biotechnology (PDSB) has 5 years of Other Accumulated Expenses data on file, last reported at $55110.0 in Q4 2018.

• Quarterly Other Accumulated Expenses fell 85.72% year-over-year to $55110.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $55110.0 (down 85.72% YoY) and the FY2018 annual result came in at $55110.0, down 85.72% from the prior year.
• Other Accumulated Expenses eased to $55110.0 in Q4 2018, from $214615.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $493399.0 in Q3 2015 to a low of $41146.0 in Q2 2016.
• A 5-year average of $238150.0 and a median of $214615.0 in 2018 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2017 — Other Accumulated Expenses surged 765.63% — and 2018, when it sank 85.72%.
• Tracing PDSB's Other Accumulated Expenses over 5 years: stood at $149738.0 in 2014, then tumbled by 62.04% to $56835.0 in 2015, then jumped by 462.04% to $319434.0 in 2016, then advanced by 20.81% to $385896.0 in 2017, then slumped by 85.72% to $55110.0 in 2018.
• The last three Other Accumulated Expenses figures came in at $55110.0 (Q4 2018), $214615.0 (Q3 2018), and $209923.0 (Q2 2018), per Business Quant data.